NCT03839758

Brief Summary

Total shoulder arthroplasty is an effective procedure to improve patients function and to relieve shoulder pain in cases of glenohumeral arthritis. The main challenge of this procedure is implanting the glenoid component. Indeed, surgical exposure is difficult and proper visualization of the glenoid is demanding. The current free-hand method is not precise and especially unreliable in glenoids with severe deformity. Inappropriate reaming and glenoid positioning can cause more bone loss during surgery. In anatomic prostheses, glenoid component fixation is demanding and is the first component to present loosening at long term follow-up. When it comes to reverse arthroplasty, the glenoid component, once again, requires the most attention. Malpositioning of the glenosphere can cause notching, loosening, and instability. In order to prevent these complications, precision in glenoid implantation is key. To this end, intraoperative computer navigation would be a helpful tool, but the increased expenses in computer equipment represent massive costs and possibly increases in surgical time. A more affordable option is a personalized guide, for which the only extra expense is the customized guide. These guides are based on precise 3D CT scan templates. Previous studies have evaluated the precision of the guide in vivo and in vitro, but none have measured it in a randomized study. As it represents additional costs, its efficacy needs to be proven before widespread use. This method may also provide secondary benefits, such as decreasing operating time, lowering short- and long-term complications, and improving efficacy. The objective of this study is to evaluate the performance of a patient specific glenoid guide.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
31mo left

Started Oct 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Oct 2019Dec 2028

First Submitted

Initial submission to the registry

February 6, 2019

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 15, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

October 8, 2019

Completed
7.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

September 22, 2025

Status Verified

September 1, 2025

Enrollment Period

7.2 years

First QC Date

February 6, 2019

Last Update Submit

September 16, 2025

Conditions

Keywords

ProthesisGlenoid implantation

Outcome Measures

Primary Outcomes (1)

  • Radiological evaluation 1

    Comparing the precision of the glenoid implantation during the surgery between both group

    2 weeks post-op

Secondary Outcomes (4)

  • Radiological evaluation 2

    2 years

  • Glenoid bone loss

    At surgery

  • Surgical time

    At surgery

  • Blood test

    Before surgery

Study Arms (4)

TSA Standard

ACTIVE COMPARATOR

This group will include patients schedule for a total shoulder arthroplasty. Glenoid preparation will be done following surgeon evaluation of the 2D CT scan with the institution software. Generic guides included in the regular instrumentation set will be used

Procedure: TSA standard

RTSA standard

ACTIVE COMPARATOR

This group will include patients schedule for a reverse total shoulder arthroplasty. Glenoid preparation will be done following surgeon evaluation of the 2D CT scan with the institution software. Generic guides included in the regular instrumentation set will be used

Procedure: RTSA standard

TSA blueprint

EXPERIMENTAL

This group will include patients schedule for a total shoulder arthroplasty. Glenoid preparation will be done using the personalized guide provided by Wright-Tornier. This guide will be ordered after CT-scan measurement, using Blueprint software prior to surgery.

Procedure: TSA Blueprint

RTSA blueprint

EXPERIMENTAL

This group will include patients schedule for a reverse total shoulder arthroplasty. Glenoid preparation will be done using the personalized guide provided by Wright-Tornier. This guide will be ordered after CT-scan measurement, using Blueprint software prior to surgery.

Procedure: RTSA Blueprint

Interventions

TSA standardPROCEDURE

Glenoid preparation will be done with 2D CT-Scan

TSA Standard
RTSA standardPROCEDURE

Glenoid preparation will be done with 2D CT-Scan

RTSA standard
TSA BlueprintPROCEDURE

Glenoid preparation will be done with Blueprint software

TSA blueprint

Glenoid preparation will be done with 2D CT-Scan

RTSA blueprint

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with shoulder osteaoarthritis and AVN

You may not qualify if:

  • Patients with previous shoulder arthroplasty
  • Patients with inflammatory arthritis and tumor
  • Patients with previous shoulder surgery with metal implant
  • Patients refusing 2-year follow-up
  • Patients that does not speak English or French
  • Patients with current or previous shoulder infection
  • Patients with graft during surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital du Sacré-Cœur de Montréal

Montreal, Quebec, H4J 1C5, Canada

RECRUITING

Study Officials

  • Dominique Rouleau, MD

    Université de Montréal

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The evaluator who will perform the follow-up clinical examination will also be blind
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Orthopaedic surgeon

Study Record Dates

First Submitted

February 6, 2019

First Posted

February 15, 2019

Study Start

October 8, 2019

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2028

Last Updated

September 22, 2025

Record last verified: 2025-09

Locations